Waters (WAT) 10-Q 9 May 23 2023 Q1 Quarterly report Financial data

Cover Page

Cover Page - shares	3 Months Ended
	Apr. 01, 2023	May 05, 2023
Cover [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Fiscal Year Focus	2023
Document Fiscal Period Focus	Q1
Entity Interactive Data Current	Yes
Entity Central Index Key	0001000697
Current Fiscal Year End Date	--12-31
Document Quarterly Report	true
Document Transition Report	false
Document Period End Date	Apr. 01, 2023
Entity Registrant Name	Waters Corporation
Entity File Number	01-14010
Entity Tax Identification Number	13-3668640
Entity Incorporation, State or Country Code	DE
Entity Current Reporting Status	Yes
Entity Filer Category	Large Accelerated Filer
Entity Shell Company	false
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Address, Address Line One	34 Maple Street
Entity Address, City or Town	Milford
Entity Address, State or Province	MA
Entity Address, Postal Zip Code	01757
City Area Code	508
Local Phone Number	478-2000
Trading Symbol	WAT
Security Exchange Name	NYSE
Title of 12(b) Security	Common Stock, par value $0.01 per share
Entity Common Stock, Shares Outstanding		59,033,571

CONSOLIDATED BALANCE SHEETS

CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Apr. 01, 2023	Dec. 31, 2022
Current assets:
Cash and cash equivalents	$ 486,070	$ 480,529
Investments	885	862
Accounts receivable, net	683,341	722,892
Inventories	499,422	455,710
Other current assets	103,981	103,910
Total current assets	1,773,699	1,763,903
Property, plant and equipment, net	590,207	582,217
Intangible assets, net	232,715	227,399
Goodwill	431,642	430,328
Operating lease assets	86,076	86,506
Other assets	192,481	191,100
Total assets	3,306,820	3,281,453
Current liabilities:
Notes payable and debt	50,040	50,000
Accounts payable	93,558	93,302
Accrued employee compensation	25,727	103,300
Deferred revenue and customer advances	306,865	227,908
Current operating lease liabilities	24,470	26,429
Accrued income taxes	150,689	132,545
Accrued warranty	12,311	11,949
Other current liabilities	138,290	140,304
Total current liabilities	801,950	785,737
Long-term liabilities:
Long-term debt	1,430,130	1,524,878
Long-term portion of retirement benefits	42,661	38,203
Long-term income tax liabilities	249,196	248,496
Long-term operating lease liabilities	62,257	62,108
Other long-term liabilities	120,803	117,543
Total long-term liabilities	1,905,047	1,991,228
Total liabilities	2,706,997	2,776,965
Commitments and contingencies (Notes 6, 7 and 8)
Stockholders' equity:
Preferred stock, par value $0.01 per share, 5,000 shares authorized, none issued at April 1, 2023 and December 31, 2022	0	0
Common stock, par value $0.01 per share, 400,000 shares authorized, 162,550 and 162,425 shares issued, 59,020 and 59,104 shares outstanding at April 1, 2023 and December 31, 2022, respectively	1,626	1,624
Additional paid-in capital	2,214,963	2,199,824
Retained earnings	8,649,510	8,508,587
Treasury stock, at cost, 103,530 and 103,321 shares at April 1, 2023 and December 31, 2022, respectively	(10,133,480)	(10,063,975)
Accumulated other comprehensive loss	(132,796)	(141,572)
Total stockholders' equity	599,823	504,488
Total liabilities and stockholders' equity	$ 3,306,820	$ 3,281,453

CONSOLIDATED BALANCE SHEETS (Pa

CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares shares in Thousands	Apr. 01, 2023	Dec. 31, 2022
Statement of Financial Position [Abstract]
Preferred stock, par value per share	$ 0.01	$ 0.01
Preferred stock, shares authorized	5,000	5,000
Preferred stock, shares issued	0	0
Common stock, par value per share	$ 0.01	$ 0.01
Common stock, shares authorized	400,000	400,000
Common stock, shares issued	162,550	162,425
Common stock, shares outstanding	59,020	59,104
Treasury stock, shares	103,530	103,321

CONSOLIDATED STATEMENTS OF OPER

CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Apr. 01, 2023	Apr. 02, 2022
Revenues:
Total net sales	$ 684,674	$ 690,572
Costs and operating expenses:
Selling and administrative expenses	181,956	157,475
Research and development expenses	42,691	40,472
Purchased intangibles amortization	1,479	1,673
Acquired in-process research and development	0	9,797
Total costs and operating expenses	510,506	495,102
Operating income	174,168	195,470
Other income, net	1,388	170
Interest expense	(14,444)	(11,059)
Interest income	4,061	2,114
Income before income taxes	165,173	186,695
Provision for income taxes	24,250	26,864
Net income	$ 140,923	$ 159,831
Net income per basic common share	$ 2.39	$ 2.64
Weighted-average number of basic common shares	59,023	60,580
Net income per diluted common share	$ 2.38	$ 2.62
Weighted-average number of diluted common shares and equivalents	59,317	60,952
Product [Member]
Revenues:
Total net sales	$ 436,457	$ 450,840
Costs and operating expenses:
Costs and operating expenses	180,354	191,610
Service [Member]
Revenues:
Total net sales	248,217	239,732
Costs and operating expenses:
Costs and operating expenses	$ 104,026	$ 94,075

CONSOLIDATED STATEMENTS OF COMP

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($) $ in Thousands	3 Months Ended
	Apr. 01, 2023	Apr. 02, 2022
Statement of Comprehensive Income [Abstract]
Net income	$ 140,923	$ 159,831
Other comprehensive income (loss):
Foreign currency translation	8,783	(6,169)
Unrealized gains on investments before income taxes	0	15
Income tax expense	0	(4)
Unrealized gains on investments, net of tax	0	11
Retirement liability adjustment before reclassifications	80	268
Amounts reclassified to other income	(83)	127
Retirement liability adjustment before income taxes	(3)	395
Income tax expense	(4)	(97)
Retirement liability adjustment, net of tax	(7)	298
Other comprehensive income (loss)	8,776	(5,860)
Comprehensive income	$ 149,699	$ 153,971

CONSOLIDATED STATEMENTS OF CASH

CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	3 Months Ended
	Apr. 01, 2023	Apr. 02, 2022
Cash flows from operating activities:
Net income	$ 140,923	$ 159,831
Adjustments to reconcile net income to net cash provided by operating activities:
Stock-based compensation	12,805	10,933
Deferred income taxes	(5,078)	4,175
Depreciation	19,411	17,209
Amortization of intangibles	11,743	15,455
Acquired in-process research and development and other non-cash items	0	9,381
Change in operating assets and liabilities:
Decrease (increase) in accounts receivable	44,047	(907)
Increase in inventories	(42,621)	(26,832)
Increase in other current assets	(2,123)	(1,805)
Decrease (increase) in other assets	6,662	(13,491)
Decrease in accounts payable and other current liabilities	(71,257)	(69,548)
Increase in deferred revenue and customer advances	77,206	91,514
Increase in other liabilities	5,033	2,045
Net cash provided by operating activities	196,751	197,960
Cash flows from investing activities:
Additions to property, plant, equipment and software capitalization	(34,390)	(27,751)
Proceeds from equity investments, net	0	6,785
Payments for intellectual property licenses	0	(4,897)
Purchases of investments	(893)	(9,219)
Maturities and sales of investments	877	54,074
Net cash (used in) provided by investing activities	(34,406)	18,992
Cash flows from financing activities:
Proceeds from debt issuances	50,040	0
Payments on debt	(145,000)	(70,000)
Proceeds from stock plans	2,378	12,832
Purchases of treasury shares	(69,505)	(170,136)
Proceeds from (payments for) derivative contracts	2,876	(107)
Net cash used in financing activities	(159,211)	(227,411)
Effect of exchange rate changes on cash and cash equivalents	2,407	(10,705)
Increase (decrease) in cash and cash equivalents	5,541	(21,164)
Cash and cash equivalents at beginning of period	480,529	501,234
Cash and cash equivalents at end of period	$ 486,070	$ 480,070

CONSOLIDATED STATEMENTS OF STOC

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($) shares in Thousands, $ in Thousands	Total	Common Stock [Member]	Additional Paid-In Capital [Member]	Retained Earnings [Member]	Treasury Stock [Member]	Accumulated Other Comprehensive Income (Loss) [Member]
Beginning balance at Dec. 31, 2021	$ 367,554	$ 1,621	$ 2,114,880	$ 7,800,832	$ (9,437,914)	$ (111,865)
Beginning Balance, shares at Dec. 31, 2021		162,084
Net income	159,831			159,831
Other comprehensive income	(5,860)					(5,860)
Issuance of common stock for Employee Stock Purchase Plan	2,327		2,327
Issuance of common stock for Employee Stock Purchase Plan, shares		7
Issuance of common stock for stock options exercised	11,092	$ 1	11,091
Issuance of common stock for stock options exercised, shares		69
Treasury stock	(170,136)				(170,136)
Stock-based compensation	10,129	$ 1	10,128
Stock-based compensation, shares		92
Ending balance at Apr. 02, 2022	374,937	$ 1,623	2,138,426	7,960,663	(9,608,050)	(117,725)
Ending Balance, shares at Apr. 02, 2022		162,252
Beginning balance at Dec. 31, 2022	504,488	$ 1,624	2,199,824	8,508,587	(10,063,975)	(141,572)
Beginning Balance, shares at Dec. 31, 2022		162,425
Net income	140,923			140,923
Other comprehensive income	8,776					8,776
Issuance of common stock for Employee Stock Purchase Plan	2,000		2,000
Issuance of common stock for Employee Stock Purchase Plan, shares		8
Issuance of common stock for stock options exercised	969	$ 0	969
Issuance of common stock for stock options exercised, shares		6
Treasury stock	(69,505)				(69,505)
Stock-based compensation	12,172	$ 2	12,170
Stock-based compensation, shares		111
Ending balance at Apr. 01, 2023	$ 599,823	$ 1,626	$ 2,214,963	$ 8,649,510	$ (10,133,480)	$ (132,796)
Ending Balance, shares at Apr. 01, 2023		162,550

Basis of Presentation and Summa

Basis of Presentation and Summary of Significant Accounting Policies	3 Months Ended
	Apr. 01, 2023
Accounting Policies [Abstract]
Basis of Presentation and Summary of Significant Accounting Policies	1 Basis of Presentation and Summary of Significant Accounting Policies Waters Corporation (the “Company,” “we,” “our,” or “us”) is a specialty measurement company that operates with a fundamental underlying purpose to advance the science that enables our customers to enhance human health and well-being. The Company has pioneered analytical workflow solutions involving liquid chromatography, mass spectrometry and thermal analysis innovations serving the life, materials and food sciences for more than 60 years. The Company primarily designs, manufactures, sells and services high-performance liquid chromatography (“HPLC”), ultra-performance liquid chromatography (“UPLC TM (“LC-MS”) LC-MS TM The Company’s interim fiscal quarter typically ends on the thirteenth Saturday of each quarter. Since the Company’s fiscal year end is December 31, the first and fourth fiscal quarters may have more or less than thirteen complete weeks. The Company’s first fiscal quarters for 2023 and 2022 ended on April 1, 2023 and April 2, 2022, respectively. The accompanying unaudited interim consolidated financial statements have been prepared in accordance with the instructions to the Quarterly Report on Form 10-Q The preparation of consolidated financial statements in conformity with U.S. GAAP requires the Company to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent liabilities at the dates of the financial statements. Actual amounts may differ from these estimates under different assumptions or conditions. It is management’s opinion that the accompanying interim consolidated financial statements reflect all adjustments (which are normal and recurring) that are necessary for a fair statement of the results for the interim periods. The interim consolidated financial statements should be read in conjunction with the consolidated financial statements included in the Company’s Annual Report on Form 10-K Risks and Uncertainties The Company is subject to risks common to companies in the analytical instrument industry, including, but not limited to, global economic and financial market conditions, fluctuations in foreign currency exchange rates, fluctuations in customer demand, development by its competitors of new technological innovations, costs of developing new technologies, levels of debt and debt service requirements, risk of disruption, dependence on key personnel, protection and litigation of proprietary technology, shifts in taxable income between tax jurisdictions and compliance with regulations of the U.S. Food and Drug Administration and similar foreign regulatory authorities and agencies. Both the Company’s domestic and international operations have been and continue to be affected by the ongoing global COVID-19 COVID-19 Through the date of the issuance of these financial statements, the Company’s consolidated financial position, results of operations and cash flows have not been materially impacted and, thus, the Company concluded that no interim goodwill or long-lived asset impairment analyses were required. Further, there have been no violations of debt covenants. Any prolonged material disruption to the Company’s employees, suppliers, manufacturing, or customers could result in a material impact to its consolidated financial position, results of operations or cash flows in the future. Translation of Foreign Currencies The functional currency of each of the Company’s foreign operating subsidiaries is the local currency of its country of domicile, except for the Company’s subsidiaries in Hong Kong, Singapore and the Cayman Islands, where the underlying transactional cash flows are denominated in currencies other than the respective local currency of domicile. The functional currency of the Hong Kong, Singapore and Cayman Islands subsidiaries is the U.S. dollar, based on the respective entity’s cash flows. For the Company’s foreign operations, assets and liabilities are translated into U.S. dollars at exchange rates prevailing on the balance sheet date, while revenues and expenses are translated at average exchange rates prevailing during the respective period. Any resulting translation gains or losses are included in accumulated other comprehensive loss in the consolidated balance sheets. Acquisition Agreement On February 14, 2023, the Company entered into an agreement to acquire all issued and outstanding equity interests of Wyatt Technology for $1.4 billion in cash at closing, subject to customary adjustments. Wyatt Technology is a pioneer in innovative light scattering and field-flow fractionation instruments, software, accessories and services. The Company will finance this acquisition through cash on its balance sheet and existing borrowing capacity that is available on its revolving credit facility. The agreement contains certain customary termination rights, including the right of the sellers to terminate this transaction if it has not been completed by June 14, 2023, subject to automatic extension to August 14, 2023 if certain regulatory approvals are not obtained by such date. If this were to occur, the Company would be required to pay the sellers a one-time Cash, Cash Equivalents and Investments Cash equivalents represent highly liquid investments, with original maturities of 90 days or less, while investments with longer maturities are classified as investments. The Company maintains cash balances in various operating accounts in excess of federally insured limits, and in foreign subsidiary accounts in currencies other than the U.S. dollar. As of April 1, 2023 and December 31, 2022, $313 million out of $487 million and $472 million out of $481 million, respectively, of the Company’s total cash, cash equivalents and investments were held by foreign subsidiaries. In addition, $188 million out of $487 million and $336 million out of $481 million of cash, cash equivalents and investments were held in currencies other than the U.S. dollar at April 1, 2023 and December 31, 2022, respectively. Accounts Receivable and Allowance for Credit Losses Trade accounts receivable are recorded at the invoiced amount and do not bear interest. The Company has very limited use of rebates and other cash considerations payable to customers and, as a result, the transaction price determination does not have any material variable consideration. The Company does not consider there to be significant concentrations of credit risk with respect to trade receivables due to the short-term nature of the balances, the Company having a large and diverse customer base, and the Company having a strong historical experience of collecting receivables with minimal defaults. As a result, credit risk is considered low across territories and trade receivables are considered to be a single class of financial asset. The allowance for credit losses is based on a number of factors and is calculated by applying a historical loss rate to trade receivable aging balances to estimate a general reserve balance along with an additional adjustment for any specific receivables with known or anticipated issues affecting the likelihood of recovery. Past due balances with a probability of default based on historical data as well as relevant available forward-looking information are included in the specific adjustment. The historical loss rate is reviewed on at least an annual basis and the allowance for credit losses is reviewed quarterly for any required adjustments. The Company does not have any off-balance Trade receivables related to instrument sales are collateralized by the instrument that is sold. If there is a risk of default related to a receivable that is collateralized, then the fair value of the collateral is calculated and adjusted for the cost to re-possess, re-sell The following is a summary of the activity of the Company’s allowance for credit losses for the three months ended April 1, 2023 and April 2, 2022 (in thousands): Balance at Additions Deductions Balance at Allowance for Credit Losses April 1, 2023 $ 14,311 $ 1,572 $ (1,028 ) $ 14,855 April 2, 2022 $ 13,228 $ 987 $ (1,072 ) $ 13,143 Other Investments During the three months ended April 1, 2023, the Company did not have any other investment activity. During the three months ended April 2, 2022, the Company recorded a realized gain of $ million in other income, net in the consolidated statement of operations due to the sale of an equity investment as well as incurring million in impairment losses on an equity investment. Fair Value Measurements In accordance with the accounting standards for fair value measurements and disclosures, certain of the Company’s assets and liabilities are measured at fair value on a recurring basis as of April 1, 2023 and December 31, 2022. Fair values determined by Level 1 inputs utilize observable data, such as quoted prices in active markets. Fair values determined by Level 2 inputs utilize data points other than quoted prices in active markets that are observable either directly or indirectly. Fair values determined by Level 3 inputs utilize unobservable data points for which there is little or no market data, which require the reporting entity to develop its own assumptions. The following table represents the Company’s assets and liabilities measured at fair value on a recurring basis at April 1, 2023 (in thousands): Total at Quoted Prices for Identical (Level 1) Significant Significant (Level 3) Assets: Time deposits $ 885 $ — $ 885 $ — Waters 401(k) Restoration Plan assets 28,310 28,310 — — Foreign currency exchange contracts 121 — 121 — Interest rate cross-currency swap agreements 13,880 — 13,880 — Total $ 43,196 $ 28,310 $ 14,886 $ — Liabilities: Foreign currency exchange contracts $ 67 $ — $ 67 $ — Interest rate cross-currency swap agreements 6,756 — 6,756 — Total $ 6,823 $ — $ 6,823 $ — The following table represents the Company’s assets and liabilities measured at fair value on a recurring basis at December 31, 2022 (in thousands): Total at Quoted Prices for Identical (Level 1) Significant Significant (Level 3) Assets: Time deposits $ 862 $ — $ 862 $ — Waters 401(k) Restoration Plan assets 25,532 25,532 — — Foreign currency exchange contracts 231 — 231 — Interest rate cross-currency swap agreements 19,163 — 19,163 — Total $ 45,788 $ 25,532 $ 20,256 $ — Liabilities: Contingent consideration $ 1,509 $ — $ — $ 1,509 Foreign currency exchange contracts 98 — 98 — Interest rate cross-currency swap agreements 4,783 — 4,783 — Total $ 6,390 $ — $ 4,881 $ 1,509 Fair Value of 401(k) Restoration Plan Assets The 401(k) Restoration Plan is a nonqualified defined contribution plan and the assets were held in registered mutual funds and have been classified as Level 1. The fair values of the assets in the plan are determined through market and observable sources from daily quoted prices on nationally recognized securities exchanges. Fair Value of Cash Equivalents, Investments, Foreign Currency Exchange Contracts and Interest Rate Cross-Currency Swap Agreements The fair values of the Company’s cash equivalents, investments, foreign currency exchange contracts and interest rate cross-currency swap agreements are determined through market and observable sources and have been classified as Level . These assets and liabilities have been initially valued at the transaction price and subsequently valued, typically utilizing third-party pricing services. The pricing services use many inputs to determine value, including reportable trades, benchmark yields, credit spreads, broker/dealer quotes, current spot rates and other industry and economic events. The Company validates the prices provided by third-party pricing services by reviewing their pricing methods and obtaining market values from other pricing sources. Fair Value of Other Financial Instruments The Company’s accounts receivable and accounts payable are recorded at cost, which approximates fair value due to their short-term nature. The carrying value of the Company’s variable interest rate debt approximates fair value due to the variable nature of the interest rate. The carrying value of the Company’s fixed interest rate debt was $1.3 billion at both April 1, 2023 and December 31, 2022. The fair value of the Company’s fixed interest rate debt was estimated using discounted cash flow models, based on estimated current rates offered for similar debt under current market conditions for the Company. The fair value of the Company’s fixed interest rate debt was estimated to be billion at both April 1, 2023 and December 31, 2022, using Level 2 inputs. Derivative Transactions The Company is a global company that operates in over 35 countries and, as a result, the Company’s net sales, cost of sales, operating expenses and balance sheet amounts are significantly impacted by fluctuations in foreign currency exchange rates. The Company is exposed to currency price risk on foreign currency exchange rate fluctuations when it translates its non-U.S. The Company’s principal strategies in managing exposures to changes in foreign currency exchange rates are to (1) naturally hedge the foreign-currency-denominated liabilities on the Company’s balance sheet against corresponding assets of the same currency, such that any changes in liabilities due to fluctuations in foreign currency exchange rates are typically offset by corresponding changes in assets and (2) mitigate foreign exchange risk exposure of international operations by hedging the variability in the movement of foreign currency exchange rates on a portion of its euro-denominated and yen-denominated Foreign Currency Exchange Contracts The Company does not specifically enter into any derivatives that hedge foreign-currency-denominated operating assets, liabilities or commitments on its balance sheet, other than a portion of certain third-party accounts receivable and accounts payable, and the Company’s net worldwide intercompany receivables and payables, which are eliminated in consolidation. The Company periodically aggregates its net worldwide balances by currency and then enters into foreign currency exchange contracts that mature within 90 days to hedge a portion of the remaining balance to minimize some of the Company’s currency price risk exposure. The foreign currency exchange contracts are not designated for hedge accounting treatment. Principal hedged currencies include the euro, Japanese yen, British pound, Mexican peso and Brazilian real. Interest Rate Cross-Currency Swap Agreements As of April 1, 2023, the Company had three-year interest rate cross-currency swap derivative agreements with an aggregate notional value of $585 million to hedge the variability in the movement of foreign currency exchange rates on a portion of its euro-denominated and yen-denominated The Company’s foreign currency exchange contracts and interest rate cross-currency swap agreements included in the consolidated balance sheets are classified as follows (in thousands): April 1, 2023 December 31, 2022 Notional Value Fair Value Notional Value Fair Value Foreign currency exchange contracts: Other current assets $ 31,461 $ 121 $ 42,047 $ 231 Other current liabilities $ 16,968 $ 67 $ 13,450 $ 98 Interest rate cross-currency swap agreements: Other assets $ 400,000 $ 13,880 $ 400,000 $ 19,163 Other liabilities $ 185,000 $ 6,756 $ 185,000 $ 4,783 Accumulated other comprehensive income $ 2,770 $ 10,026 The following is a summary of the activity included in the consolidated statements of operations and statements of comprehensive income related to the foreign currency exchange contracts and interest rate cross-currency swap agreements (in thousands): Financial Statement Three Months Ended April 1, 2023 April 2, 2022 Foreign currency exchange contracts: Realized gains (losses) on closed contracts Cost of sales $ 30 $ (1,499 ) Unrealized losses on open contracts Cost of sales (78 ) (489 ) Cumulative net pre-tax Cost of sales $ (48 ) $ (1,988 ) Interest rate cross-currency swap agreements: Interest earned Interest income $ 2,655 $ 1,775 Unrealized (losses) gains Accumulated other $ (7,256 ) $ 12,188 Stockholders’ Equity In January 2019, the Company’s Board of Directors authorized the Company to repurchase up to $ billion of its outstanding common stock over a two-year period. This program such that it shall now expire on and increased the total billion, an increase of $ million. During the three months ended April 1, 2023 and April 2, 2022, the Company repurchased million shares of the Company’s outstanding common stock at a cost of $ million, respectively, under the January 2019 authorization and other previously announced programs. In addition, the Company repurchased $ million of common stock related to the vesting of restricted stock units during the three months ended April 1, 2023 and April 2, 2022, respectively. As of April 1, 2023, the Company had repurchased an aggregate of million shares at a cost of $ billion under the January 2019 repurchase program and had a total of $1.0 billion authorized for future repurchases. While the Company believes that it has the financial flexibility to fund these share repurchases, as well as to invest in research, technology and business acquisitions, given current cash levels and debt borrowing capacity, it has temporarily suspended its share repurchases due to its recently announced agreement to acquire Wyatt Technology. Product Warranty Costs The Company accrues estimated product warranty costs at the time of sale, which are included in cost of sales in the consolidated statements of operations. While the Company engages in extensive product quality programs and processes, including actively monitoring and evaluating the quality of its component suppliers, the Company’s warranty obligation is affected by product failure rates, material usage and service delivery costs incurred in correcting a product failure. The amount of the accrued warranty liability is based on historical information, such as past experience, product failure rates, number of units repaired and estimated costs of material and labor. The liability is reviewed for reasonableness at least quarterly. The following is a summary of the activity of the Company’s accrued warranty liability for the three Balance at Accruals for Settlements Balance at Accrued warranty liability: April 1, 2023 $ 11,949 $ 2,177 $ (1,815 ) $ 12,311 April 2, 2022 $ 10,718 $ 1,916 $ (2,422 ) $ 10,212

Revenue Recognition

Revenue Recognition	3 Months Ended
	Apr. 01, 2023
Revenue from Contract with Customer [Abstract]
Revenue Recognition	2 Revenue Recognition The Company’s deferred revenue liabilities i The following is a summary of the activity of the Company’s deferred revenue and customer advances for the three months ended April 1, 2023 and April 2, 2022 (in thousands): April 1, 2023 April 2, 2022 Balance at the beginning of the period $ 285,175 $ 273,598 Recognition of revenue included in balance at beginning of the period (105,222 ) (103,355 ) Revenue deferred during the period, net of revenue recognized 193,286 198,036 Balance at the end of the period $ 373,239 $ 368,279 The Company classified $66 million and $57 million of deferred revenue and customer advances in other long-term liabilities at April 1, 2023 and December 31, 2022, respectively. The amount of deferred revenue and customer advances equals the transaction price allocated to unfulfilled performance obligations for the period presented. Such amounts are expected to be recognized in the future as follows (in thousands): April 1, 2023 Deferred revenue and customer advances expected to be recognized in: One year or less $ 306,865 13-24 40,785 25 months and beyond 25,589 Total $ 373,239

Marketable Securities

Marketable Securities	3 Months Ended
	Apr. 01, 2023
Investments, Debt and Equity Securities [Abstract]
Marketable Securities	3 Marketable Securities The Company’s marketable securities within cash equivalents and investments included in the consolidated balance sheets consist of time deposits that mature in one year or less with an amortized cost and a fair value of $0.9 million at both April 1, 2023 and December 31, 2022.

Inventories

Inventories	3 Months Ended
	Apr. 01, 2023
Inventory Disclosure [Abstract]
Inventories	4 Inventories Inventories are classified as follows (in thousands): April 1, 2023 December 31, 2022 Raw materials $ 217,120 $ 205,760 Work in progress 24,380 19,899 Finished goods 257,922 230,051 Total inventories $ 499,422 $ 455,710

Goodwill and Other Intangibles

Goodwill and Other Intangibles	3 Months Ended
	Apr. 01, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill and Other Intangibles	5 Goodwill and Other Intangibles The carrying amount of goodwill was $432 million and $430 million at April 1, 2023 and December 31, 2022, respectively. The effect of foreign currency translation increased The Company’s intangible assets included in the consolidated balance sheets are detailed as follows (dollars in thousands): April 1, 2023 December 31, 2022 Gross Accumulated Weighted- Gross Accumulated Weighted- Capitalized software $ 610,668 $ 455,952 5years $ 589,604 $ 441,414 5years Purchased intangibles 198,395 168,787 11years 197,805 166,735 11years Trademarks 9,680 — — 9,680 — — Licenses 14,339 7,186 6years 14,070 6,729 6years Patents and other intangibles 106,660 75,102 8years 104,139 73,021 8years Total $ 939,742 $ 707,027 7years $ 915,298 $ 687,899 7years The Company capitalized $14 million and $12 million of intangible assets in the three months ended April 1, 2023 and April 2, 2022, respectively. The gross carrying value of intangible assets and accumulated amortization for intangible assets increased by $ million, respectively, in the three months ended April 1, 2023 due to the effects of foreign currency translation. Amortization expense for intangible assets was $ be

Debt

Debt	3 Months Ended
	Apr. 01, 2023
Debt Disclosure [Abstract]
Debt	6 Debt The Company has a five-year, $1.8 billion revolving facility (the “Credit Facility”) that expires in September 2026. On March 3, 2023, the Company amended the Credit Facility to increase the borrowing capacity by $200 million to an aggregate total borrowing capacity of $2.0 billion, which did not affect the maturity date of September 17, 2026. The amendment also replaced all references in the Credit Facility to LIBOR with Term SOFR as the benchmark rate. As of April 1, 2023 and December 31, 2022, the Credit Facility had a total of $ The interest rates applicable under the Credit Facility are, at the Company’s option, equal to either the alternate base rate (which is a rate per annum equal to the greatest of (1) the prime rate in effect on such day, (2) the Federal Reserve Bank of New York Rate on such day plus 1/2 of 1% per annum and (3) the adjusted Term SOFR rate for a one—month interest period as published two U.S. Government Securities Business Days prior to such day (or if such day is not a U.S. Government Securities Business Day, the immediately preceding U.S. Government Securities Business Day), plus 1% annum) or the applicable 1, 3 or 6 month adjusted Term SOFR or EURIBO rate for euro—denominated loans, in each case, plus an interest rate margin based upon the Company’s leverage ratio, which can range between 0 and 12.5 basis points for alternate base rate loans and between 80 and 112.5 basis points for Term SOFR or EURIBO rate loans. The facility fee on the Credit Facility ranges between 7.5 and 25 basis points per annum, based on the leverage ratio, of the amount of the revolving facility commitments and the outstanding term loan. The Credit Facility requires that the Company comply with an interest coverage ratio test of not less than 3.50:1 as of the end of any fiscal quarter for any period of four consecutive fiscal quarters and a leverage ratio test of not more than 3.50:1 as of the end of any fiscal quarter. In addition, the Credit Facility includes negative covenants, affirmative covenants, representations and warranties and events of default that are customary for investment grade credit facilities. As of both April 1, 2023 and December 31, 2022, the Company had a total of $ 1.3 billion of outstanding senior unsecured notes. Interest on the fixed rate senior unsecured notes is payable semi—annually each year. Interest on the floating rate senior unsecured notes is payable quarterly. T Company may prepay all or some of the senior unsecured notes at any time in an amount not less than 10 % of the aggregate principal amount outstanding, plus the applicable make—whole amount or prepayment premium for the Series H senior unsecured note. In the event of a change in control of the Company (as defined in the note purchase agreement), the Company may be required to prepay the senior unsecured notes at a price equal to 100% of the principal amount thereof, plus accrued and unpaid interest. These senior unsecured notes require that the Company comply with an interest coverage ratio test of not less than 3.50 : 1 for any period of four consecutive fiscal quarters and a leverage ratio test of not more than 3.50 :1 as of the end of any fiscal quarter. In addition, these senior unsecured notes include customary negative covenants, affirmative covenants, representations and warranties and events of default. The Company had the following outstanding debt at April 1, 2023 and December 31, 2022 (in thousands): April 1, 2023 December 31, 2022 Foreign subsidiary lines of credit $ 40 $ — Senior unsecured notes—Series I - 50,000 50,000 Total notes payable and debt, current 50,040 50,000 Senior unsecured notes—Series G - 50,000 50,000 Senior unsecured notes—Series H - 50,000 50,000 Senior unsecured notes—Series K - 160,000 160,000 Senior unsecured notes—Series L - 200,000 200,000 Senior unsecured notes—Series M - 300,000 300,000 Senior unsecured notes—Series N - 100,000 100,000 Senior unsecured notes—Series O - 400,000 400,000 Credit agreement 175,000 270,000 Unamortized debt issuance costs (4,870 ) (5,122 ) Total long-term debt 1,430,130 1,524,878 Total debt $ 1,480,170 $ 1,574,878 * Series H senior unsecured notes bear interest at a 3-month LIBOR for that floating rate interest period plus As of April 1, 2023 and December 31, 2022, the Company had a total amount available to borrow under the Credit Facility of $1.8 billion and $1.5 billion, respectively, after outstanding letters of credit. The weighted-average interest rates applicable to the senior unsecured notes and credit agreement borrowings collectively were 3.50% and 3.54% at April 1, 2023 and December 31, 2022, respectively. As of April 1, 2023, the Company was in compliance with all debt covenants. The Company and its foreign subsidiaries also had available short-term lines of credit totaling $114 million and $ m As of April 1, 2023, the Company had entered into interest rate cross-currency swap derivative agreements with an aggregate notional value of $ million to hedge the variability in the movement of foreign currency exchange rates on a portion of its euro-denominated and yen-denominated net asset investments.

Income Taxes

Income Taxes	3 Months Ended
	Apr. 01, 2023
Income Tax Disclosure [Abstract]
Income Taxes	7 Income Taxes The four principal jurisdictions in which the Company manufactures are the U.S., Ireland, the U.K. and Singapore, where the statutory tax rates were 21%, 12.5%, 25% and 17%, respectively, as of April 1, 2023. The Company has a Development and Expansion Incentive in Singapore that provides a concessionary income tax rate of 5% on certain types of income for the period April 1, 2021 through March 31, 2026. The effect of applying the concessionary income tax rate rather than the statutory tax rate to income arising from qualifying activities in Singapore increased the Company’s net income for the three months ended by $3 million and The Company’s effective tax rate for the months en de d April , and April , was % and %, respectively. The income tax provision includes a $ 2 4 The Company accounts for its uncertain tax return positions in accordance with the accounting standards for income taxes, which require financial statement reporting of the expected future tax consequences of uncertain tax reporting positions on the presumption that all concerned tax authorities possess full knowledge of those tax reporting positions, as well as all of the pertinent facts and circumstances, but prohibit any discounting of unrecognized tax benefits associated with those reporting positions for the time value of money. The Company continues to classify interest and penalties related to unrecognized tax benefits as a component of the provision for income taxes. The Company’s gross unrecognized tax benefits, excluding interest and penalties, at April 1, 2023 and April 2, 2022 were $30 million and $ million, respectively. With limited exceptions, the Company is no longer subject to tax audit examinations in significant jurisdictions for the years ended on or before December 31, 2017. The Company continuously monitors the lapsing of statutes of limitations on potential tax assessments for related changes in the measurement of unrecognized tax benefits, related net interest and penalties, and deferred tax assets and liabilities. As of April 1, 2023, the Company expects to record reductions in the measurement of its unrecognized tax benefits and related net interest and penalties of $ million within the next twelve months due to potential tax audit settlements and the lapsing of statutes of limitations on potential tax assessments. The Company does not expect to record any other material reductions in the measurement of its unrecognized tax benefits within the next twelve months.

Other Commitments and Contingen

Other Commitments and Contingencies	3 Months Ended
	Apr. 01, 2023
Commitments and Contingencies Disclosure [Abstract]
Other Commitments and Contingencies	8 Other Commitments and Contingencies The Company licenses certain technology and software from third parties in the course of ordinary business. Future minimum license fees payable under existing license agreements as of April 1, 2023 are immaterial for the years ended December 31, 2023 and thereafter. The Company enters into standard indemnification agreements in its ordinary course of business. Pursuant to these agreements, the Company indemnifies, holds harmless and agrees to reimburse the indemnified party for losses suffered or incurred by the indemnified party, generally the Company’s business partners or customers, in connection with patent, copyright or other intellectual property infringement claims by any third party with respect to its current products, as well as claims relating to property damage or personal injury resulting from the performance of services by the Company or its subcontractors. The maximum potential amount of future payments the Company could be required to make under these indemnification agreements is unlimited. Historically, the Company’s costs to defend lawsuits or settle claims relating to such indemnity agreements have been minimal and management accordingly believes the estimated fair value of these agreements is immaterial.

Earnings Per Share

Earnings Per Share	3 Months Ended
	Apr. 01, 2023
Earnings Per Share [Abstract]
Earnings Per Share	9 Earnings Per Share Basic and diluted EPS calculations are detailed as follows (in thousands, except per share data): Three Months Ended April 1, 2023 Net Income Weighted- Per Share Net income per basic common share $ 140,923 59,023 $ 2.39 Effect of dilutive stock option, restricted stock, performance stock unit and restricted stock unit securities — 294 (0.01 ) Net income per diluted common share $ 140,923 59,317 $ 2.38 Three Months Ended April 2, 2022 Net Income Weighted- Per Share Net income per basic common share $ 159,831 60,580 $ 2.64 Effect of dilutive stock option, restricted stock, performance stock unit and restricted stock unit securities — 372 (0.02 ) Net income per diluted common share $ 159,831 60,952 $ 2.62 For the three months ended April 1, 2023 and April 2, 2022, the Company had 140 thousand and 12 thousand stock options that were antidilutive, respectively, due to having higher exercise prices than the Company’s average stock price during the period. These securities were not included in the computation of diluted EPS. The effect of dilutive securities was calculated using the treasury stock method.

Accumulated Other Comprehensive

Accumulated Other Comprehensive Income (Loss)	3 Months Ended
	Apr. 01, 2023
Equity [Abstract]
Accumulated Other Comprehensive Income (Loss)	10 Accumulated Other Comprehensive Income (Loss) The components of accumulated other comprehensive income (loss) are detailed as follows (in thousands): Currency Translation Unrealized Gain (Loss) Accumulated Other Balance at December 31, 2022 $ (146,120 ) $ 4,548 $ (141,572 ) Other comprehensive (loss) income, net of tax 8,783 (7 ) 8,776 Balance at April 1, 2023 $ (137,337 ) $ 4,541 $ (132,796 )

Business Segment Information

Business Segment Information	3 Months Ended
	Apr. 01, 2023
Segment Reporting [Abstract]
Business Segment Information	11 Business Segment Information The Company’s business activities, for which discrete financial information is available, are regularly reviewed and evaluated by the chief operating decision maker. As a result of this evaluation, the Company determined that it has two operating segments: Waters TM TM The Waters operating segment is primarily in the business of designing, manufacturing, selling and servicing LC and MS instruments, columns and other precision chemistry consumables that can be integrated and used along with other analytical instruments. The TA operating segment is primarily in the business of designing, manufacturing, selling and servicing thermal analysis, rheometry and calorimetry instruments. The Company’s operating segments have similar economic characteristics; product processes; products and services; types and classes of customers; methods of distribution; and regulatory environments. Because of these similarities, the segments have been aggregated into reporting segment for financial statement purposes. Please refer to the consolidated financial statements for financial information regarding the reportable segment of the Company. Net sales for the Company’s products and services are as follows for the three months ended April 1, 2023 and April 2, 2022 (in thousands): Three Months Ended April 1, 2023 April 2, 2022 Product net sales: Waters instrument systems $ 244,211 $ 269,962 Chemistry consumables 133,515 125,618 TA instrument systems 58,731 55,260 Total product sales 436,457 450,840 Service net sales: Waters service 224,349 217,576 TA service 23,868 22,156 Total service sales 248,217 239,732 Total net sales $ 684,674 $ 690,572 Net sales are attributable to geographic areas based on the region of destination. Geographic sales information is presented below for the three months ended April 1, 2023 and April 2, 2022 (in thousands): Three Months Ended April 1, 2023 April 2, 2022 Net Sales: Asia: China $ 116,065 $ 121,032 Japan 46,494 48,623 Asia Other 90,522 84,679 Total Asia 253,081 254,334 Americas: United States 202,305 208,713 Americas Other 44,116 40,124 Total Americas 246,421 248,837 Europe 185,172 187,401 Total net sales $ 684,674 $ 690,572 Net sales by customer class are as follows for the three months ended April 1, 2023 and April 2, 2022 (in thousands): Three Months Ended April 1, 2023 April 2, 2022 Pharmaceutical $ 384,898 $ 415,772 Industrial 209,650 209,397 Academic and government 90,126 65,403 Total net sales $ 684,674 $ 690,572 Net sales for the Company recognized at a point in time versus over time are as follows for the three months ended April 1, 2023 and April 2, 2022 (in thousands): Three Months Ended April 1, 2023 April 2, 2022 Net sales recognized at a point in time: Instrument systems $ 302,942 $ 325,222 Chemistry consumables 133,515 125,618 Service sales recognized at a point in time (time & materials) 88,207 85,778 Total net sales recognized at a point in time 524,664 536,618 Net sales recognized over time: Service and software maintenance sales recognized over time (contracts) 160,010 153,954 Total net sales $ 684,674 $ 690,572

Recent Accounting Standard Chan

Recent Accounting Standard Changes and Developments	3 Months Ended
	Apr. 01, 2023
Accounting Changes and Error Corrections [Abstract]
Recent Accounting Standard Changes and Developments	12 Recent Accounting Standard Changes and Developments Recently Adopted Accounting Standards In October 2021, accounting guidance was issued that requires acquirers in a business combination to recognize and measure contract assets and contract liabilities acquired in a business combination in accordance with Topic 606. The new guidance requires that at the acquisition date, the acquirer should account for the related revenue contracts in accordance with 606 as if it had originated the contracts. This guidance differs from current GAAP which requires an acquirer to recognize assets acquired and liabilities assumed in a business combination, including contract assets and contract liabilities arising from revenue contracts with customers and other similar contracts that are accounted for in accordance with 606, at fair value on the acquisition date. This guidance is effective for public business entities for fiscal years beginning after December 15, 2022, including interim periods within those years. The Company adopted this standard on January 1, 2023. The adoption of this standard did not have a material impact on the Company’s financial position, results of operations and cash flows. Recently Issued Accounting Standards In March 2020, accounting guidance was issued that facilitates the effects of reference rate reform on financial reporting. The amendments in the update provide optional guidance for a limited period of time to ease the potential burden in accounting for or recognizing the effects of reference rate reform on financial reporting and apply to all entities, subject to meeting certain criteria, that have contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform. In January of 2021, an update was issued to clarify that certain optional expedients and exceptions under the reference rate reform guidance for contract modifications and hedge accounting apply to derivatives that are affected by the discounting transition. Specifically, certain provisions in the reference rate reform guidance, if elected by an entity, apply to derivative instruments that use an interest rate for margining, discounting, or contract price alignment that is modified as a result of reference rate reform. This temporary guidance is effective for all entities as of March 12, 2020, through December 31, 2022. In December 2022, an update was issued because the cessation date for overnight LIBOR rates being published was extended to June 30, 2023, which was beyond the current expiration date of this guidance. The update extended the sunset date to December 31, 2024. The Company may elect to apply this guidance for all contract modifications or eligible hedging relationships during that time period subject to certain criteria. The Company does not believe that it has material reference rate exposure which would require utilizing the guidance under this accounting pronouncement and if adopted does not believe that this standard would have a material impact on the Company’s financial position, results of operations and cash flows.

Basis of Presentation and Sum_2

Basis of Presentation and Summary of Significant Accounting Policies (Policies)	3 Months Ended
	Apr. 01, 2023
Accounting Policies [Abstract]
Fiscal Period	The Company’s interim fiscal quarter typically ends on the thirteenth Saturday of each quarter. Since the Company’s fiscal year end is December 31, the first and fourth fiscal quarters may have more or less than thirteen complete weeks. The Company’s first fiscal quarters for 2023 and 2022 ended on April 1, 2023 and April 2, 2022, respectively.
Basis of Accounting	The accompanying unaudited interim consolidated financial statements have been prepared in accordance with the instructions to the Quarterly Report on Form 10-Q The preparation of consolidated financial statements in conformity with U.S. GAAP requires the Company to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent liabilities at the dates of the financial statements. Actual amounts may differ from these estimates under different assumptions or conditions. It is management’s opinion that the accompanying interim consolidated financial statements reflect all adjustments (which are normal and recurring) that are necessary for a fair statement of the results for the interim periods. The interim consolidated financial statements should be read in conjunction with the consolidated financial statements included in the Company’s Annual Report on Form 10-K
Use of Estimates	The preparation of consolidated financial statements in conformity with U.S. GAAP requires the Company to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent liabilities at the dates of the financial statements. Actual amounts may differ from these estimates under different assumptions or conditions.
Risks and Uncertainties	Risks and Uncertainties The Company is subject to risks common to companies in the analytical instrument industry, including, but not limited to, global economic and financial market conditions, fluctuations in foreign currency exchange rates, fluctuations in customer demand, development by its competitors of new technological innovations, costs of developing new technologies, levels of debt and debt service requirements, risk of disruption, dependence on key personnel, protection and litigation of proprietary technology, shifts in taxable income between tax jurisdictions and compliance with regulations of the U.S. Food and Drug Administration and similar foreign regulatory authorities and agencies. Both the Company’s domestic and international operations have been and continue to be affected by the ongoing global COVID-19 COVID-19 Through the date of the issuance of these financial statements, the Company’s consolidated financial position, results of operations and cash flows have not been materially impacted and, thus, the Company concluded that no interim goodwill or long-lived asset impairment analyses were required. Further, there have been no violations of debt covenants. Any prolonged material disruption to the Company’s employees, suppliers, manufacturing, or customers could result in a material impact to its consolidated financial position, results of operations or cash flows in the future.
Principles of Consolidation	The consolidated financial statements include the accounts of the Company and its subsidiaries, which are wholly owned. All inter-company balances and transactions have been eliminated.
Translation of Foreign Currencies	Translation of Foreign Currencies The functional currency of each of the Company’s foreign operating subsidiaries is the local currency of its country of domicile, except for the Company’s subsidiaries in Hong Kong, Singapore and the Cayman Islands, where the underlying transactional cash flows are denominated in currencies other than the respective local currency of domicile. The functional currency of the Hong Kong, Singapore and Cayman Islands subsidiaries is the U.S. dollar, based on the respective entity’s cash flows. For the Company’s foreign operations, assets and liabilities are translated into U.S. dollars at exchange rates prevailing on the balance sheet date, while revenues and expenses are translated at average exchange rates prevailing during the respective period. Any resulting translation gains or losses are included in accumulated other comprehensive loss in the consolidated balance sheets.
Acquisition Agreement	Acquisition Agreement On February 14, 2023, the Company entered into an agreement to acquire all issued and outstanding equity interests of Wyatt Technology for $1.4 billion in cash at closing, subject to customary adjustments. Wyatt Technology is a pioneer in innovative light scattering and field-flow fractionation instruments, software, accessories and services. The Company will finance this acquisition through cash on its balance sheet and existing borrowing capacity that is available on its revolving credit facility. The agreement contains certain customary termination rights, including the right of the sellers to terminate this transaction if it has not been completed by June 14, 2023, subject to automatic extension to August 14, 2023 if certain regulatory approvals are not obtained by such date. If this were to occur, the Company would be required to pay the sellers a one-time
Cash, Cash Equivalents and Investments	Cash, Cash Equivalents and Investments Cash equivalents represent highly liquid investments, with original maturities of 90 days or less, while investments with longer maturities are classified as investments. The Company maintains cash balances in various operating accounts in excess of federally insured limits, and in foreign subsidiary accounts in currencies other than the U.S. dollar. As of April 1, 2023 and December 31, 2022, $313 million out of $487 million and $472 million out of $481 million, respectively, of the Company’s total cash, cash equivalents and investments were held by foreign subsidiaries. In addition, $188 million out of $487 million and $336 million out of $481 million of cash, cash equivalents and investments were held in currencies other than the U.S. dollar at April 1, 2023 and December 31, 2022, respectively.
Accounts Receivable and Allowance for Credit Losses	Accounts Receivable and Allowance for Credit Losses Trade accounts receivable are recorded at the invoiced amount and do not bear interest. The Company has very limited use of rebates and other cash considerations payable to customers and, as a result, the transaction price determination does not have any material variable consideration. The Company does not consider there to be significant concentrations of credit risk with respect to trade receivables due to the short-term nature of the balances, the Company having a large and diverse customer base, and the Company having a strong historical experience of collecting receivables with minimal defaults. As a result, credit risk is considered low across territories and trade receivables are considered to be a single class of financial asset. The allowance for credit losses is based on a number of factors and is calculated by applying a historical loss rate to trade receivable aging balances to estimate a general reserve balance along with an additional adjustment for any specific receivables with known or anticipated issues affecting the likelihood of recovery. Past due balances with a probability of default based on historical data as well as relevant available forward-looking information are included in the specific adjustment. The historical loss rate is reviewed on at least an annual basis and the allowance for credit losses is reviewed quarterly for any required adjustments. The Company does not have any off-balance Trade receivables related to instrument sales are collateralized by the instrument that is sold. If there is a risk of default related to a receivable that is collateralized, then the fair value of the collateral is calculated and adjusted for the cost to re-possess, re-sell The following is a summary of the activity of the Company’s allowance for credit losses for the three months ended April 1, 2023 and April 2, 2022 (in thousands): Balance at Additions Deductions Balance at Allowance for Credit Losses April 1, 2023 $ 14,311 $ 1,572 $ (1,028 ) $ 14,855 April 2, 2022 $ 13,228 $ 987 $ (1,072 ) $ 13,143
Other Investments	Other Investments During the three months ended April 1, 2023, the Company did not have any other investment activity. During the three months ended April 2, 2022, the Company recorded a realized gain of $ million in other income, net in the consolidated statement of operations due to the sale of an equity investment as well as incurring million in impairment losses on an equity investment.
Fair Value Measurements	Fair Value Measurements In accordance with the accounting standards for fair value measurements and disclosures, certain of the Company’s assets and liabilities are measured at fair value on a recurring basis as of April 1, 2023 and December 31, 2022. Fair values determined by Level 1 inputs utilize observable data, such as quoted prices in active markets. Fair values determined by Level 2 inputs utilize data points other than quoted prices in active markets that are observable either directly or indirectly. Fair values determined by Level 3 inputs utilize unobservable data points for which there is little or no market data, which require the reporting entity to develop its own assumptions. The following table represents the Company’s assets and liabilities measured at fair value on a recurring basis at April 1, 2023 (in thousands): Total at Quoted Prices for Identical (Level 1) Significant Significant (Level 3) Assets: Time deposits $ 885 $ — $ 885 $ — Waters 401(k) Restoration Plan assets 28,310 28,310 — — Foreign currency exchange contracts 121 — 121 — Interest rate cross-currency swap agreements 13,880 — 13,880 — Total $ 43,196 $ 28,310 $ 14,886 $ — Liabilities: Foreign currency exchange contracts $ 67 $ — $ 67 $ — Interest rate cross-currency swap agreements 6,756 — 6,756 — Total $ 6,823 $ — $ 6,823 $ — The following table represents the Company’s assets and liabilities measured at fair value on a recurring basis at December 31, 2022 (in thousands): Total at Quoted Prices for Identical (Level 1) Significant Significant (Level 3) Assets: Time deposits $ 862 $ — $ 862 $ — Waters 401(k) Restoration Plan assets 25,532 25,532 — — Foreign currency exchange contracts 231 — 231 — Interest rate cross-currency swap agreements 19,163 — 19,163 — Total $ 45,788 $ 25,532 $ 20,256 $ — Liabilities: Contingent consideration $ 1,509 $ — $ — $ 1,509 Foreign currency exchange contracts 98 — 98 — Interest rate cross-currency swap agreements 4,783 — 4,783 — Total $ 6,390 $ — $ 4,881 $ 1,509 Fair Value of 401(k) Restoration Plan Assets The 401(k) Restoration Plan is a nonqualified defined contribution plan and the assets were held in registered mutual funds and have been classified as Level 1. The fair values of the assets in the plan are determined through market and observable sources from daily quoted prices on nationally recognized securities exchanges. Fair Value of Cash Equivalents, Investments, Foreign Currency Exchange Contracts and Interest Rate Cross-Currency Swap Agreements The fair values of the Company’s cash equivalents, investments, foreign currency exchange contracts and interest rate cross-currency swap agreements are determined through market and observable sources and have been classified as Level . These assets and liabilities have been initially valued at the transaction price and subsequently valued, typically utilizing third-party pricing services. The pricing services use many inputs to determine value, including reportable trades, benchmark yields, credit spreads, broker/dealer quotes, current spot rates and other industry and economic events. The Company validates the prices provided by third-party pricing services by reviewing their pricing methods and obtaining market values from other pricing sources. Fair Value of Other Financial Instruments The Company’s accounts receivable and accounts payable are recorded at cost, which approximates fair value due to their short-term nature. The carrying value of the Company’s variable interest rate debt approximates fair value due to the variable nature of the interest rate. The carrying value of the Company’s fixed interest rate debt was $1.3 billion at both April 1, 2023 and December 31, 2022. The fair value of the Company’s fixed interest rate debt was estimated using discounted cash flow models, based on estimated current rates offered for similar debt under current market conditions for the Company. The fair value of the Company’s fixed interest rate debt was estimated to be billion at both April 1, 2023 and December 31, 2022, using Level 2 inputs.
Derivative Transactions	Derivative Transactions The Company is a global company that operates in over 35 countries and, as a result, the Company’s net sales, cost of sales, operating expenses and balance sheet amounts are significantly impacted by fluctuations in foreign currency exchange rates. The Company is exposed to currency price risk on foreign currency exchange rate fluctuations when it translates its non-U.S. The Company’s principal strategies in managing exposures to changes in foreign currency exchange rates are to (1) naturally hedge the foreign-currency-denominated liabilities on the Company’s balance sheet against corresponding assets of the same currency, such that any changes in liabilities due to fluctuations in foreign currency exchange rates are typically offset by corresponding changes in assets and (2) mitigate foreign exchange risk exposure of international operations by hedging the variability in the movement of foreign currency exchange rates on a portion of its euro-denominated and yen-denominated Foreign Currency Exchange Contracts The Company does not specifically enter into any derivatives that hedge foreign-currency-denominated operating assets, liabilities or commitments on its balance sheet, other than a portion of certain third-party accounts receivable and accounts payable, and the Company’s net worldwide intercompany receivables and payables, which are eliminated in consolidation. The Company periodically aggregates its net worldwide balances by currency and then enters into foreign currency exchange contracts that mature within 90 days to hedge a portion of the remaining balance to minimize some of the Company’s currency price risk exposure. The foreign currency exchange contracts are not designated for hedge accounting treatment. Principal hedged currencies include the euro, Japanese yen, British pound, Mexican peso and Brazilian real. Interest Rate Cross-Currency Swap Agreements As of April 1, 2023, the Company had three-year interest rate cross-currency swap derivative agreements with an aggregate notional value of $585 million to hedge the variability in the movement of foreign currency exchange rates on a portion of its euro-denominated and yen-denominated The Company’s foreign currency exchange contracts and interest rate cross-currency swap agreements included in the consolidated balance sheets are classified as follows (in thousands): April 1, 2023 December 31, 2022 Notional Value Fair Value Notional Value Fair Value Foreign currency exchange contracts: Other current assets $ 31,461 $ 121 $ 42,047 $ 231 Other current liabilities $ 16,968 $ 67 $ 13,450 $ 98 Interest rate cross-currency swap agreements: Other assets $ 400,000 $ 13,880 $ 400,000 $ 19,163 Other liabilities $ 185,000 $ 6,756 $ 185,000 $ 4,783 Accumulated other comprehensive income $ 2,770 $ 10,026 The following is a summary of the activity included in the consolidated statements of operations and statements of comprehensive income related to the foreign currency exchange contracts and interest rate cross-currency swap agreements (in thousands): Financial Statement Three Months Ended April 1, 2023 April 2, 2022 Foreign currency exchange contracts: Realized gains (losses) on closed contracts Cost of sales $ 30 $ (1,499 ) Unrealized losses on open contracts Cost of sales (78 ) (489 ) Cumulative net pre-tax Cost of sales $ (48 ) $ (1,988 ) Interest rate cross-currency swap agreements: Interest earned Interest income $ 2,655 $ 1,775 Unrealized (losses) gains Accumulated other $ (7,256 ) $ 12,188
Stockholders' (Deficit) Equity	Stockholders’ Equity In January 2019, the Company’s Board of Directors authorized the Company to repurchase up to $ billion of its outstanding common stock over a two-year period. This program such that it shall now expire on and increased the total billion, an increase of $ million. During the three months ended April 1, 2023 and April 2, 2022, the Company repurchased million shares of the Company’s outstanding common stock at a cost of $ million, respectively, under the January 2019 authorization and other previously announced programs. In addition, the Company repurchased $ million of common stock related to the vesting of restricted stock units during the three months ended April 1, 2023 and April 2, 2022, respectively. As of April 1, 2023, the Company had repurchased an aggregate of million shares at a cost of $ billion under the January 2019 repurchase program and had a total of $1.0 billion authorized for future repurchases. While the Company believes that it has the financial flexibility to fund these share repurchases, as well as to invest in research, technology and business acquisitions, given current cash levels and debt borrowing capacity, it has temporarily suspended its share repurchases due to its recently announced agreement to acquire Wyatt Technology.
Product Warranty Costs	Product Warranty Costs The Company accrues estimated product warranty costs at the time of sale, which are included in cost of sales in the consolidated statements of operations. While the Company engages in extensive product quality programs and processes, including actively monitoring and evaluating the quality of its component suppliers, the Company’s warranty obligation is affected by product failure rates, material usage and service delivery costs incurred in correcting a product failure. The amount of the accrued warranty liability is based on historical information, such as past experience, product failure rates, number of units repaired and estimated costs of material and labor. The liability is reviewed for reasonableness at least quarterly. The following is a summary of the activity of the Company’s accrued warranty liability for the three Balance at Accruals for Settlements Balance at Accrued warranty liability: April 1, 2023 $ 11,949 $ 2,177 $ (1,815 ) $ 12,311 April 2, 2022 $ 10,718 $ 1,916 $ (2,422 ) $ 10,212

Basis of Presentation and Sum_3

Basis of Presentation and Summary of Significant Accounting Policies (Tables)	3 Months Ended
	Apr. 01, 2023
Accounting Policies [Abstract]
Summary of Activity of Company's Allowance for Doubtful Accounts	The following is a summary of the activity of the Company’s allowance for credit losses for the three months ended April 1, 2023 and April 2, 2022 (in thousands): Balance at Additions Deductions Balance at Allowance for Credit Losses April 1, 2023 $ 14,311 $ 1,572 $ (1,028 ) $ 14,855 April 2, 2022 $ 13,228 $ 987 $ (1,072 ) $ 13,143
Summary of Assets and Liabilities Measured at Fair Value on Recurring Basis	The following table represents the Company’s assets and liabilities measured at fair value on a recurring basis at April 1, 2023 (in thousands): Total at Quoted Prices for Identical (Level 1) Significant Significant (Level 3) Assets: Time deposits $ 885 $ — $ 885 $ — Waters 401(k) Restoration Plan assets 28,310 28,310 — — Foreign currency exchange contracts 121 — 121 — Interest rate cross-currency swap agreements 13,880 — 13,880 — Total $ 43,196 $ 28,310 $ 14,886 $ — Liabilities: Foreign currency exchange contracts $ 67 $ — $ 67 $ — Interest rate cross-currency swap agreements 6,756 — 6,756 — Total $ 6,823 $ — $ 6,823 $ — The following table represents the Company’s assets and liabilities measured at fair value on a recurring basis at December 31, 2022 (in thousands): Total at Quoted Prices for Identical (Level 1) Significant Significant (Level 3) Assets: Time deposits $ 862 $ — $ 862 $ — Waters 401(k) Restoration Plan assets 25,532 25,532 — — Foreign currency exchange contracts 231 — 231 — Interest rate cross-currency swap agreements 19,163 — 19,163 — Total $ 45,788 $ 25,532 $ 20,256 $ — Liabilities: Contingent consideration $ 1,509 $ — $ — $ 1,509 Foreign currency exchange contracts 98 — 98 — Interest rate cross-currency swap agreements 4,783 — 4,783 — Total $ 6,390 $ — $ 4,881 $ 1,509
Summary of Foreign Currency Exchange Contracts and Interest Rate Cross-Currency Swap Agreements	The Company’s foreign currency exchange contracts and interest rate cross-currency swap agreements included in the consolidated balance sheets are classified as follows (in thousands): April 1, 2023 December 31, 2022 Notional Value Fair Value Notional Value Fair Value Foreign currency exchange contracts: Other current assets $ 31,461 $ 121 $ 42,047 $ 231 Other current liabilities $ 16,968 $ 67 $ 13,450 $ 98 Interest rate cross-currency swap agreements: Other assets $ 400,000 $ 13,880 $ 400,000 $ 19,163 Other liabilities $ 185,000 $ 6,756 $ 185,000 $ 4,783 Accumulated other comprehensive income $ 2,770 $ 10,026
Gains (Losses) on Foreign Exchange Contracts	The following is a summary of the activity included in the consolidated statements of operations and statements of comprehensive income related to the foreign currency exchange contracts and interest rate cross-currency swap agreements (in thousands): Financial Statement Three Months Ended April 1, 2023 April 2, 2022 Foreign currency exchange contracts: Realized gains (losses) on closed contracts Cost of sales $ 30 $ (1,499 ) Unrealized losses on open contracts Cost of sales (78 ) (489 ) Cumulative net pre-tax Cost of sales $ (48 ) $ (1,988 ) Interest rate cross-currency swap agreements: Interest earned Interest income $ 2,655 $ 1,775 Unrealized (losses) gains Accumulated other $ (7,256 ) $ 12,188
Summary of Activity of Company's Accrued Warranty Liability	The following is a summary of the activity of the Company’s accrued warranty liability for the three Balance at Accruals for Settlements Balance at Accrued warranty liability: April 1, 2023 $ 11,949 $ 2,177 $ (1,815 ) $ 12,311 April 2, 2022 $ 10,718 $ 1,916 $ (2,422 ) $ 10,212

Revenue Recognition (Tables)

Revenue Recognition (Tables)	3 Months Ended
	Apr. 01, 2023
Revenue from Contract with Customer [Abstract]
Summary of Activity of Deferred Revenue and Customer Advances	The following is a summary of the activity of the Company’s deferred revenue and customer advances for the three months ended April 1, 2023 and April 2, 2022 (in thousands): April 1, 2023 April 2, 2022 Balance at the beginning of the period $ 285,175 $ 273,598 Recognition of revenue included in balance at beginning of the period (105,222 ) (103,355 ) Revenue deferred during the period, net of revenue recognized 193,286 198,036 Balance at the end of the period $ 373,239 $ 368,279
Schedule of Amount of Deferred Revenue and Customer Advances	The amount of deferred revenue and customer advances equals the transaction price allocated to unfulfilled performance obligations for the period presented. Such amounts are expected to be recognized in the future as follows (in thousands): April 1, 2023 Deferred revenue and customer advances expected to be recognized in: One year or less $ 306,865 13-24 40,785 25 months and beyond 25,589 Total $ 373,239

Inventories (Tables)

Inventories (Tables)	3 Months Ended
	Apr. 01, 2023
Inventory Disclosure [Abstract]
Inventory, Net of Reserves	Inventories are classified as follows (in thousands): April 1, 2023 December 31, 2022 Raw materials $ 217,120 $ 205,760 Work in progress 24,380 19,899 Finished goods 257,922 230,051 Total inventories $ 499,422 $ 455,710

Goodwill and Other Intangibles

Goodwill and Other Intangibles (Tables)	3 Months Ended
	Apr. 01, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Intangible Assets	The Company’s intangible assets included in the consolidated balance sheets are detailed as follows (dollars in thousands): April 1, 2023 December 31, 2022 Gross Accumulated Weighted- Gross Accumulated Weighted- Capitalized software $ 610,668 $ 455,952 5years $ 589,604 $ 441,414 5years Purchased intangibles 198,395 168,787 11years 197,805 166,735 11years Trademarks 9,680 — — 9,680 — — Licenses 14,339 7,186 6years 14,070 6,729 6years Patents and other intangibles 106,660 75,102 8years 104,139 73,021 8years Total $ 939,742 $ 707,027 7years $ 915,298 $ 687,899 7years

Debt (Tables)

Debt (Tables)	3 Months Ended
	Apr. 01, 2023
Debt Disclosure [Abstract]
Summary of Outstanding Debt	April 1, 2023 December 31, 2022 Foreign subsidiary lines of credit $ 40 $ — Senior unsecured notes—Series I - 50,000 50,000 Total notes payable and debt, current 50,040 50,000 Senior unsecured notes—Series G - 50,000 50,000 Senior unsecured notes—Series H - 50,000 50,000 Senior unsecured notes—Series K - 160,000 160,000 Senior unsecured notes—Series L - 200,000 200,000 Senior unsecured notes—Series M - 300,000 300,000 Senior unsecured notes—Series N - 100,000 100,000 Senior unsecured notes—Series O - 400,000 400,000 Credit agreement 175,000 270,000 Unamortized debt issuance costs (4,870 ) (5,122 ) Total long-term debt 1,430,130 1,524,878 Total debt $ 1,480,170 $ 1,574,878 * Series H senior unsecured notes bear interest at a 3-month LIBOR for that floating rate interest period plus

Earnings Per Share (Tables)

Earnings Per Share (Tables)	3 Months Ended
	Apr. 01, 2023
Earnings Per Share [Abstract]
Earnings Per Share Reconciliation	Basic and diluted EPS calculations are detailed as follows (in thousands, except per share data): Three Months Ended April 1, 2023 Net Income Weighted- Per Share Net income per basic common share $ 140,923 59,023 $ 2.39 Effect of dilutive stock option, restricted stock, performance stock unit and restricted stock unit securities — 294 (0.01 ) Net income per diluted common share $ 140,923 59,317 $ 2.38 Three Months Ended April 2, 2022 Net Income Weighted- Per Share Net income per basic common share $ 159,831 60,580 $ 2.64 Effect of dilutive stock option, restricted stock, performance stock unit and restricted stock unit securities — 372 (0.02 ) Net income per diluted common share $ 159,831 60,952 $ 2.62

Accumulated Other Comprehensi_2

Accumulated Other Comprehensive Income (Loss) (Tables)	3 Months Ended
	Apr. 01, 2023
Equity [Abstract]
Schedule of Accumulated Other Comprehensive Income (Loss)	The components of accumulated other comprehensive income (loss) are detailed as follows (in thousands): Currency Translation Unrealized Gain (Loss) Accumulated Other Balance at December 31, 2022 $ (146,120 ) $ 4,548 $ (141,572 ) Other comprehensive (loss) income, net of tax 8,783 (7 ) 8,776 Balance at April 1, 2023 $ (137,337 ) $ 4,541 $ (132,796 )

Business Segment Information (T

Business Segment Information (Tables)	3 Months Ended
	Apr. 01, 2023
Segment Reporting [Abstract]
Summary of Net Sales for Company's Products and Services	Net sales for the Company’s products and services are as follows for the three months ended April 1, 2023 and April 2, 2022 (in thousands): Three Months Ended April 1, 2023 April 2, 2022 Product net sales: Waters instrument systems $ 244,211 $ 269,962 Chemistry consumables 133,515 125,618 TA instrument systems 58,731 55,260 Total product sales 436,457 450,840 Service net sales: Waters service 224,349 217,576 TA service 23,868 22,156 Total service sales 248,217 239,732 Total net sales $ 684,674 $ 690,572
Summary of Geographic Sales Information	Net sales are attributable to geographic areas based on the region of destination. Geographic sales information is presented below for the three months ended April 1, 2023 and April 2, 2022 (in thousands): Three Months Ended April 1, 2023 April 2, 2022 Net Sales: Asia: China $ 116,065 $ 121,032 Japan 46,494 48,623 Asia Other 90,522 84,679 Total Asia 253,081 254,334 Americas: United States 202,305 208,713 Americas Other 44,116 40,124 Total Americas 246,421 248,837 Europe 185,172 187,401 Total net sales $ 684,674 $ 690,572
Summary of Net Sales by Customer Class	Net sales by customer class are as follows for the three months ended April 1, 2023 and April 2, 2022 (in thousands): Three Months Ended April 1, 2023 April 2, 2022 Pharmaceutical $ 384,898 $ 415,772 Industrial 209,650 209,397 Academic and government 90,126 65,403 Total net sales $ 684,674 $ 690,572
Summary of Net Sales of Company Recognized at a Point in Time Versus Over Time	Net sales for the Company recognized at a point in time versus over time are as follows for the three months ended April 1, 2023 and April 2, 2022 (in thousands): Three Months Ended April 1, 2023 April 2, 2022 Net sales recognized at a point in time: Instrument systems $ 302,942 $ 325,222 Chemistry consumables 133,515 125,618 Service sales recognized at a point in time (time & materials) 88,207 85,778 Total net sales recognized at a point in time 524,664 536,618 Net sales recognized over time: Service and software maintenance sales recognized over time (contracts) 160,010 153,954 Total net sales $ 684,674 $ 690,572

Basis of Presentation and Sum_4

Basis of Presentation and Summary of Significant Accounting Policies - Additional Information (Detail) - USD ($) shares in Millions		1 Months Ended	3 Months Ended
	Feb. 14, 2023	Jan. 31, 2019	Apr. 01, 2023	Apr. 02, 2022	Dec. 31, 2022	Jul. 02, 2022
Basis of Presentation and Summary of Significant Accounting Policies [Line Items]
Cash equivalents description			Cash equivalents represent highly liquid investments, with original maturities of 90 days or less, while investments with longer maturities are classified as investments.
Cash, cash equivalents and investments			$ 487,000,000		$ 481,000,000
Long-term debt			$ 1,430,130,000		1,524,878,000
Foreign currency exposure			The Company is a global company that operates in over 35 countries and, as a result, the Company’s net sales, cost of sales, operating expenses and balance sheet amounts are significantly impacted by fluctuations in foreign currency exchange rates.
Maturity period of foreign exchange contracts			The Company periodically aggregates its net worldwide balances by currency and then enters into foreign currency exchange contracts that mature within 90 days to hedge a portion of the remaining balance to minimize some of the Company’s currency price risk exposure. The foreign currency exchange contracts are not designated for hedge accounting treatment.
Treasury stock			$ 69,505,000	$ 170,136,000
Equity method investment, other than temporary impairment				4,000,000
Gain (Loss) on Investments				$ 4,000,000
Wyatt Technology [Member]
Basis of Presentation and Summary of Significant Accounting Policies [Line Items]
Business Acquisation Termination Fee	$ 15,000,000
Payments to acquire businesses, gross	$ 1,400,000,000
Cross Currency Interest Rate Contract [Member]
Basis of Presentation and Summary of Significant Accounting Policies [Line Items]
Notional value, derivative asset			$ 585,000,000
Programs Authorized by Board of Directors [Member]
Basis of Presentation and Summary of Significant Accounting Policies [Line Items]
Treasury stock shares acquired			0.2	0.5
Treasury stock			$ 58,000,000	$ 160,000,000
Related to Vesting of Restricted Stock Units [Member]
Basis of Presentation and Summary of Significant Accounting Policies [Line Items]
Treasury stock			$ 11,000,000	10,000,000
January 2019 Program [Member]
Basis of Presentation and Summary of Significant Accounting Policies [Line Items]
Stock repurchase program period		2 years
Treasury stock shares acquired			15.2
Treasury stock				$ 3,800,000,000
Stock repurchase program remaining amount authorized for future purchases						$ 1,000,000,000
Amended and extended January 2019 Program [Member]
Basis of Presentation and Summary of Significant Accounting Policies [Line Items]
Increase in stock repurchase program authorization amount					750,000,000
Stock repurchase program, extension term			1 year
Stock repurchase program expiration date			Jan. 21, 2024
Held In Currencies Other Than Us Dollars [Member]
Basis of Presentation and Summary of Significant Accounting Policies [Line Items]
Cash, cash equivalents and investments			$ 188,000,000		336,000,000
January 2019 Program [Member]
Basis of Presentation and Summary of Significant Accounting Policies [Line Items]
Stock repurchase program authorization amount		$ 4,000,000,000
Unsecured Debt [Member]
Basis of Presentation and Summary of Significant Accounting Policies [Line Items]
Long-term debt			1,300,000,000		1,300,000,000
Unsecured Debt [Member] | Fixed Interest Rate [Member]
Basis of Presentation and Summary of Significant Accounting Policies [Line Items]
Long-term debt			1,300,000,000		1,300,000,000
Fair value of fixed interest rate debt			1,100,000,000		1,100,000,000
Maximum [Member] | Amended and extended January 2019 Program [Member]
Basis of Presentation and Summary of Significant Accounting Policies [Line Items]
Stock repurchase program authorization amount					4,800,000,000
Held By Foreign Subsidiaries [Member]
Basis of Presentation and Summary of Significant Accounting Policies [Line Items]
Cash, cash equivalents and investments			$ 313,000,000		$ 472,000,000

Basis of Presentation and Sum_5

Basis of Presentation and Summary of Significant Accounting Policies - Allowance for Doubtful Accounts Roll Forward (Detail) - USD ($) $ in Thousands	3 Months Ended
	Apr. 01, 2023	Apr. 02, 2022
Allowance for Doubtful Accounts Receivable [Roll Forward]
Beginning balance	$ 14,311	$ 13,228
Additions	1,572	987
Deduction	(1,028)	(1,072)
Ending balance	$ 14,855	$ 13,143

Basis of Presentation and Sum_6

Basis of Presentation and Summary of Significant Accounting Policies - Summary of Assets and Liabilities Measured at Fair Value on Recurring Basis (Detail) - USD ($) $ in Thousands	Apr. 01, 2023	Dec. 31, 2022
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Waters 401(k) Restoration Plan assets	$ 28,310	$ 25,532
Total	43,196	45,788
Contingent consideration		1,509
Total	6,823	6,390
Foreign Currency Exchange Contract [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value, derivative asset	121	231
Foreign currency exchange contracts	67	98
Cross Currency Interest Rate Contract [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value, derivative asset	13,880	19,163
Foreign currency exchange contracts	6,756	4,783
Time Deposits [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available for sale securities	885	862
Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 1 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Waters 401(k) Restoration Plan assets	28,310	25,532
Total	28,310	25,532
Total	0	0
Fair Value, Measurements, Recurring [Member] | Significant Unobservable Inputs (Level 2) [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Waters 401(k) Restoration Plan assets	0
Total	14,886	20,256
Total	6,823	4,881
Fair Value, Measurements, Recurring [Member] | Significant Unobservable Inputs (Level 2) [Member] | Foreign Currency Exchange Contract [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value, derivative asset	121	231
Foreign currency exchange contracts	67	98
Fair Value, Measurements, Recurring [Member] | Significant Unobservable Inputs (Level 2) [Member] | Cross Currency Interest Rate Contract [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value, derivative asset	13,880	19,163
Foreign currency exchange contracts	6,756	4,783
Fair Value, Measurements, Recurring [Member] | Significant Unobservable Inputs (Level 3) [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total	0	0
Contingent consideration		1,509
Total	$ 0	$ 1,509

Basis of Presentation and Sum_7

Basis of Presentation and Summary of Significant Accounting Policies - Fair Value of Forward Foreign Exchange Contracts (Detail) - USD ($)	Apr. 01, 2023	Dec. 31, 2022
Foreign Currency Exchange Contract [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value, derivative asset	$ 121,000	$ 231,000
Fair value, derivative liability	67,000	98,000
Cross Currency Interest Rate Contract [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Notional value, derivative asset	585,000,000
Fair value, derivative asset	13,880,000	19,163,000
Fair value, derivative liability	6,756,000	4,783,000
Other Current Assets [Member] | Foreign Currency Exchange Contract [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Notional value, derivative asset	31,461,000	42,047,000
Fair value, derivative asset	121,000	231,000
Other Current Liabilities [Member] | Foreign Currency Exchange Contract [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Notional value, derivative liability	16,968,000	13,450,000
Fair value, derivative liability	67,000	98,000
Other Assets [Member] | Cross Currency Interest Rate Contract [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Notional value, derivative asset	400,000,000
Notional value, derivative liability		400,000,000
Fair value, derivative asset	13,880,000	19,163,000
Other Liabilities [Member] | Cross Currency Interest Rate Contract [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Notional value, derivative liability	185,000,000	185,000,000
Fair value, derivative liability	6,756,000	4,783,000
Accumulated other comprehensive income | Cross Currency Interest Rate Contract [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value, derivative asset	$ 2,770,000	$ 10,026,000

Basis of Presentation and Sum_8

Basis of Presentation and Summary of Significant Accounting Policies - Gains (Losses) on Foreign Exchange Contracts (Detail) - USD ($) $ in Thousands	3 Months Ended
	Apr. 01, 2023	Apr. 02, 2022
Cross Currency Interest Rate Contract [Member]
Derivative [Line Items]
Interest earned	$ 2,655	$ 1,775
Cost of Sales [Member] | Foreign Currency Exchange Contract [Member]
Derivative [Line Items]
Realized gains (losses) on closed contracts	30	(1,499)
Unrealized losses on open contracts	(78)	(489)
Cumulative net pre-tax losses	(48)	(1,988)
Stockholders' (Deficit) Equity [Member] | Cross Currency Interest Rate Contract [Member]
Derivative [Line Items]
Unrealized (losses) gains on contracts, net	$ (7,256)	$ 12,188

Basis of Presentation and Sum_9

Basis of Presentation and Summary of Significant Accounting Policies - Summary of Activity of Company's Accrued Warranty Liability (Detail) - USD ($) $ in Thousands	3 Months Ended
	Apr. 01, 2023	Apr. 02, 2022
Movement in Standard Product Warranty Accrual [Roll Forward]
Balance at Beginning of Period	$ 11,949	$ 10,718
Accruals for Warranties	2,177	1,916
Settlements Made	(1,815)	(2,422)
Balance at End of Period	$ 12,311	$ 10,212

Revenue Recognition - Additiona

Revenue Recognition - Additional Information (Detail) - USD ($) $ in Millions	Apr. 01, 2023	Dec. 31, 2022
Other Long-Term Liabilities [Member]
Revenue Recognition [Line Items]
Deferred revenue and customer advances	$ 66	$ 57

Revenue Recognition - Summary o

Revenue Recognition - Summary of Activity of the Company's Deferred Revenue and Customer Advances (Detail) - USD ($) $ in Thousands	3 Months Ended
	Apr. 01, 2023	Apr. 02, 2022
Revenue Recognition and Deferred Revenue [Abstract]
Balance at the beginning of the period	$ 285,175	$ 273,598
Recognition of revenue included in balance at beginning of the period	(105,222)	(103,355)
Revenue deferred during the period, net of revenue recognized	193,286	198,036
Balance at the end of the period	$ 373,239	$ 368,279

Revenue Recognition - Schedule

Revenue Recognition - Schedule of Estimated Amount of Deferred Revenue and Customer Advances (Detail) - USD ($) $ in Thousands	Apr. 01, 2023	Dec. 31, 2022
Revenue Recognition [Line Items]
Deferred revenue and customer advances expected to be recognized	$ 306,865	$ 227,908
Deferred revenue and customer advances expected to be recognized	373,239
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-12-31
Revenue Recognition [Line Items]
Deferred revenue and customer advances expected to be recognized	$ 306,865
Deferred revenue and customer advances recognition period	1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-12-31
Revenue Recognition [Line Items]
Deferred revenue and customer advances expected to be recognized	$ 40,785
Deferred revenue and customer advances recognition period	24 months
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2025-12-31
Revenue Recognition [Line Items]
Deferred revenue and customer advances expected to be recognized	$ 25,589
Deferred revenue and customer advances recognition period	25 months

Marketable Securities - Additio

Marketable Securities - Additional Information (Detail) - USD ($) $ in Millions	Apr. 01, 2023	Dec. 31, 2022
Investments, Debt and Equity Securities [Abstract]
Time Deposits	$ 0.9	$ 0.9

Inventories - Inventory, Net of

Inventories - Inventory, Net of Reserves (Detail) - USD ($) $ in Thousands	Apr. 01, 2023	Dec. 31, 2022
Inventory, Net, Items Net of Reserve Alternative [Abstract]
Raw materials	$ 217,120	$ 205,760
Work in progress	24,380	19,899
Finished goods	257,922	230,051
Total inventories	$ 499,422	$ 455,710

Goodwill and Other Intangible_2

Goodwill and Other Intangibles - Additional Information (Detail) - USD ($) $ in Thousands	3 Months Ended
	Apr. 01, 2023	Apr. 02, 2022	Dec. 31, 2022
Goodwill	$ 431,642		$ 430,328
Goodwill foreign currency translation adjustments	2,000
Intangible assets, gross foreign currency translation adjustments	(10,000)
Intangible assets, accumulated amortization foreign currency translation adjustments		$ (8,000)
Amortization expense	12,000	15,000
Future amortization expense, year 1	49,000
Future amortization expense, year 2	49,000
Future amortization expense, year 3	49,000
Future amortization expense, year 4	49,000
Future amortization expense, year 5	49,000
Intangible assets other than goodwill capitalized during the period	$ 14,000	$ 12,000

Goodwill and Other Intangible_3

Goodwill and Other Intangibles - Schedule of Intangible Assets (Detail) - USD ($) $ in Thousands	3 Months Ended	12 Months Ended
	Apr. 01, 2023	Dec. 31, 2022
Finite Lived and Indefinite Lived Intangible Assets [Line Items]
Gross Carrying Amount	$ 939,742	$ 915,298
Accumulated Amortization	$ 707,027	$ 687,899
Weighted-Average Amortization Period	7 years	7 years
Trademarks [Member]
Finite Lived and Indefinite Lived Intangible Assets [Line Items]
Gross Carrying Amount	$ 9,680	$ 9,680
Software Development [Member]
Finite Lived and Indefinite Lived Intangible Assets [Line Items]
Gross Carrying Amount	610,668	589,604
Accumulated Amortization	$ 455,952	$ 441,414
Weighted-Average Amortization Period	5 years	5 years
Purchased Intangibles [Member]
Finite Lived and Indefinite Lived Intangible Assets [Line Items]
Gross Carrying Amount	$ 198,395	$ 197,805
Accumulated Amortization	$ 168,787	$ 166,735
Weighted-Average Amortization Period	11 years	11 years
Licensing Agreements [Member]
Finite Lived and Indefinite Lived Intangible Assets [Line Items]
Gross Carrying Amount	$ 14,339	$ 14,070
Accumulated Amortization	$ 7,186	$ 6,729
Weighted-Average Amortization Period	6 years	6 years
Patents and Other Intangibles [Member]
Finite Lived and Indefinite Lived Intangible Assets [Line Items]
Gross Carrying Amount	$ 106,660	$ 104,139
Accumulated Amortization	$ 75,102	$ 73,021
Weighted-Average Amortization Period	8 years	8 years

Debt - Additional Information (

Debt - Additional Information (Detail) - USD ($)	3 Months Ended
	Apr. 01, 2023	Mar. 03, 2023	Dec. 31, 2022	Sep. 17, 2021
Debt Instrument [Line Items]
Debt facility fee	The interest rates applicable under the Credit Facility are, at the Company’s option, equal to either the alternate base rate (which is a rate per annum equal to the greatest of (1) the prime rate in effect on such day, (2) the Federal Reserve Bank of New York Rate on such day plus 1/2 of 1% per annum and (3) the adjusted Term SOFR rate for a one—month interest period as published two U.S. Government Securities Business Days prior to such day (or if such day is not a U.S. Government Securities Business Day, the immediately preceding U.S. Government Securities Business Day), plus 1% annum) or the applicable 1, 3 or 6 month adjusted Term SOFR or EURIBO rate for euro—denominated loans, in each case, plus an interest rate margin based upon the Company’s leverage ratio, which can range between 0 and 12.5 basis points for alternate base rate loans and between 80 and 112.5 basis points for Term SOFR or EURIBO rate loans. The facility fee on the Credit Facility ranges between 7.5 and 25 basis points per annum, based on the leverage ratio, of the amount of the revolving facility commitments and the outstanding term loan.
Long-term debt	$ 1,430,130,000		$ 1,524,878,000
Line of credit maximum borrowing capacity	114,000,000	$ 2,000,000,000	113,000,000
Cross Currency Interest Rate Contract [Member]
Debt Instrument [Line Items]
Notional value, derivative asset	$ 585,000,000
Derivative instrument, term	3 years
Notes Payable to Banks [Member]
Debt Instrument [Line Items]
Unused borrowing capacity	$ 1,800,000,000		1,500,000,000
Unsecured Debt [Member]
Debt Instrument [Line Items]
Debt covenant description	These senior unsecured notes require that the Company comply with an interest coverage ratio test of not less than 3.50:1 for any period of four consecutive fiscal quarters and a leverage ratio test of not more than 3.50:1 as of the end of any fiscal quarter. In addition, these senior unsecured notes include customary negative covenants, affirmative covenants, representations and warranties and events of default.
Long-term debt	$ 1,300,000,000		$ 1,300,000,000
Call feature on debt instrument	The Company may prepay all or some of the senior unsecured notes at any time in an amount not less than 10% of the aggregate principal amount outstanding, plus the applicable make—whole amount or prepayment premium for the Series H senior unsecured note. In the event of a change in control of the Company (as defined in the note purchase agreement), the Company may be required to prepay the senior unsecured notes at a price equal
Debt instrument percentage of the amount to be prepaid	10%
Debt instrument interest coverage ratio	3.50%
Debt instrument leverage ratio	3.50%
Credit Agreements and Unsecured Debt [Member]
Debt Instrument [Line Items]
Weighted-average interest rate	3.50%		3.54%
Revolving Facilities [Member]
Debt Instrument [Line Items]
Face value of debt				$ 1,800,000,000
2021 Credit Facility
Debt Instrument [Line Items]
Long term debt gross	$ 175,000,000		$ 270,000,000
Debt Instrument, Term	5 years
Revolving Credit Facility [Member]
Debt Instrument [Line Items]
Line of credit maximum borrowing capacity		$ 200,000,000

Debt - Summary of Outstanding D

Debt - Summary of Outstanding Debt (Detail) - USD ($) $ in Thousands	Apr. 01, 2023	Dec. 31, 2022
Debt Instrument [Line Items]
Total notes payable and debt, current	$ 50,040	$ 50,000
Unamortized debt issuance costs	(4,870)	(5,122)
Total long-term debt	1,430,130	1,524,878
Total debt	1,480,170	1,574,878
Foreign Line of Credit [Member]
Debt Instrument [Line Items]
Total notes payable and debt, current	40
Credit Agreement [Member]
Debt Instrument [Line Items]
Long-term debt	175,000	270,000
Senior Unsecured Notes Series G [Member]
Debt Instrument [Line Items]
Total notes payable and debt, current	50,000	50,000
Senior Unsecured Notes Series H [Member]
Debt Instrument [Line Items]
Total notes payable and debt, current	50,000	50,000
Senior Unsecured Notes Series I [Member]
Debt Instrument [Line Items]
Total notes payable and debt, current	50,000	50,000
Senior Unsecured Notes Series K [Member]
Debt Instrument [Line Items]
Long-term debt	160,000	160,000
Senior Unsecured Notes Series L [Member]
Debt Instrument [Line Items]
Long-term debt	200,000	200,000
Senior Unsecured Notes Series M [Member]
Debt Instrument [Line Items]
Long-term debt	300,000	300,000
Senior Unsecured Notes Series N [Member]
Debt Instrument [Line Items]
Long-term debt	100,000	100,000
Senior Unsecured Notes Series O [Member]
Debt Instrument [Line Items]
Long-term debt	$ 400,000	$ 400,000

Debt - Summary of Outstanding_2

Debt - Summary of Outstanding Debt (Parenthetical) (Detail)	3 Months Ended	12 Months Ended
	Apr. 01, 2023	Dec. 31, 2022
Senior Unsecured Notes Series G [Member]
Debt Instrument [Line Items]
Stated interest rate on debt instrument	3.92%	3.92%
Senior Unsecured Notes Series H [Member] | LIBOR [Member]
Debt Instrument [Line Items]
Interest rate margin	1.25%	1.25%
Senior Unsecured Notes Series I [Member]
Debt Instrument [Line Items]
Stated interest rate on debt instrument	3.13%	3.13%
Senior Unsecured Notes Series K [Member]
Debt Instrument [Line Items]
Stated interest rate on debt instrument	3.44%	3.44%
Senior Unsecured Notes Series L [Member]
Debt Instrument [Line Items]
Stated interest rate on debt instrument	3.31%	3.31%
Senior Unsecured Notes Series M [Member]
Debt Instrument [Line Items]
Stated interest rate on debt instrument	3.53%	3.53%
Senior Unsecured Notes Series N [Member]
Debt Instrument [Line Items]
Stated interest rate on debt instrument	1.68%	1.68%
Senior Unsecured Notes Series O [Member]
Debt Instrument [Line Items]
Stated interest rate on debt instrument	2.25%	2.25%

Income Taxes - Additional Infor

Income Taxes - Additional Information (Detail) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended
	Apr. 01, 2023	Apr. 02, 2022
Income Taxes [Line Items]
Income tax holiday amount	$ 3,000	$ 5,000
Income tax holiday per share benefit	$ 0.05	$ 0.08
Effective income tax rate	14.70%	14.40%
Incremental income tax provision	$ 24,250	$ 26,864
Gross unrecognized tax benefit would impact the Company's effective tax rate	30,000	29,000
Stock Based Compensation Tax Benefit [Member]
Income Taxes [Line Items]
Incremental income tax provision	2,000	$ 4,000
Maximum [Member]
Income Taxes [Line Items]
Expected change in unrecognized tax benefits in the next twelve months	$ 18,000
United States [Member]
Income Taxes [Line Items]
Statutory tax rate	21%
Ireland [Member]
Income Taxes [Line Items]
Statutory tax rate	12.50%
U.K [Member]
Income Taxes [Line Items]
Statutory tax rate	25%
Singapore [Member]
Income Taxes [Line Items]
Statutory tax rate	17%
Singapore [Member] | April Two Thousand And Twenty One To March Two Thousand And Twenty Six [Member] | New Contractual Arrangement [Member]
Income Taxes [Line Items]
Statutory tax rate	5%

Other Commitments and Conting_2

Other Commitments and Contingencies Additional Information (Detail)	3 Months Ended
	Apr. 01, 2023
Commitments and Contingencies Disclosure [Abstract]
Future Minimum License Fees Payable	Future minimum license fees payable under existing license agreements as of April 1, 2023 are immaterial for the years ended December 31, 2023 and thereafter.

Earnings Per Share - Earnings P

Earnings Per Share - Earnings Per Share Reconciliation (Detail) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended
	Apr. 01, 2023	Apr. 02, 2022
Earnings Per Share [Abstract]
Net income per basic common share, Net Income (Numerator)	$ 140,923	$ 159,831
Effect of dilutive stock option, restricted stock, performance stock unit and restricted stock unit securities, Net Income	0	0
Net income per diluted common share, Net Income (Numerator)	$ 140,923	$ 159,831
Net income per basic common share, Weighted-Average Shares (Denominator)	59,023	60,580
Effect of dilutive stock option, restricted stock, performance stock unit and restricted stock unit securities, Weighted-Average Shares (Denominator)	294	372
Net income per diluted common share, Weighted-Average Shares (Denominator)	59,317	60,952
Net income per basic common share, Per Share Amount	$ 2.39	$ 2.64
Effect of dilutive stock option, restricted stock, performance stock unit and restricted stock unit securities, Per Share Amount	(0.01)	(0.02)
Net income per diluted common share, Per Share Amount	$ 2.38	$ 2.62

Earnings Per Share - Additional

Earnings Per Share - Additional Information (Detail) - shares shares in Thousands	3 Months Ended
	Apr. 01, 2023	Apr. 02, 2022
Earnings Per Share [Abstract]
Antidilutive securities excluded from computation of earnings per share	140	12

Accumulated Other Comprehensi_3

Accumulated Other Comprehensive Income (Loss) - Schedule of Accumulated Other Comprehensive Income (Loss) (Detail) - USD ($) $ in Thousands	3 Months Ended
	Apr. 01, 2023	Apr. 02, 2022
Accumulated Other Comprehensive Income (Loss) [Line Items]
Beginning balance	$ 504,488	$ 367,554
Other comprehensive (loss) income, net of tax	8,776	(5,860)
Ending balance	599,823	374,937
Currency Translation [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Beginning balance	(146,120)
Other comprehensive (loss) income, net of tax	8,783
Ending balance	(137,337)
Unrealized Gain (Loss) on Retirement Plans [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Beginning balance	4,548
Other comprehensive (loss) income, net of tax	(7)
Ending balance	4,541
Accumulated Other Comprehensive Loss [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Beginning balance	(141,572)	(111,865)
Other comprehensive (loss) income, net of tax	8,776
Ending balance	$ (132,796)	$ (117,725)

Business Segment Information -

Business Segment Information - Additional Information (Detail)	3 Months Ended
	Apr. 01, 2023 Segment
Segment Reporting [Abstract]
Number of operating segments	2
Number of reportable segments	1

Business Segment Information _2

Business Segment Information - Summary of Net Sales for Company's Products and Services (Detail) - USD ($) $ in Thousands	3 Months Ended
	Apr. 01, 2023	Apr. 02, 2022
Disaggregation of Revenue [Line Items]
Total net sales	$ 684,674	$ 690,572
Waters Instrument Systems [Member]
Disaggregation of Revenue [Line Items]
Total net sales	244,211	269,962
Chemistry Consumables [Member]
Disaggregation of Revenue [Line Items]
Total net sales	133,515	125,618
TA Instrument Systems [Member]
Disaggregation of Revenue [Line Items]
Total net sales	58,731	55,260
Product [Member]
Disaggregation of Revenue [Line Items]
Total net sales	436,457	450,840
Waters Service [Member]
Disaggregation of Revenue [Line Items]
Total net sales	224,349	217,576
TA Service [Member]
Disaggregation of Revenue [Line Items]
Total net sales	23,868	22,156
Service [Member]
Disaggregation of Revenue [Line Items]
Total net sales	$ 248,217	$ 239,732

Business Segment Information _3

Business Segment Information - Summary of Geographic Sales Information (Detail) - USD ($) $ in Thousands	3 Months Ended
	Apr. 01, 2023	Apr. 02, 2022
Disaggregation of Revenue [Line Items]
Total net sales	$ 684,674	$ 690,572
China [Member]
Disaggregation of Revenue [Line Items]
Total net sales	116,065	121,032
Japan [Member]
Disaggregation of Revenue [Line Items]
Total net sales	46,494	48,623
Asia Other [Member]
Disaggregation of Revenue [Line Items]
Total net sales	90,522	84,679
Total Asia [Member]
Disaggregation of Revenue [Line Items]
Total net sales	253,081	254,334
United States [Member]
Disaggregation of Revenue [Line Items]
Total net sales	202,305	208,713
Americas Other [Member]
Disaggregation of Revenue [Line Items]
Total net sales	44,116	40,124
Total Americas [Member]
Disaggregation of Revenue [Line Items]
Total net sales	246,421	248,837
Europe [Member]
Disaggregation of Revenue [Line Items]
Total net sales	$ 185,172	$ 187,401

Business Segment Information _4

Business Segment Information - Summary of Net Sales by Customer Class (Detail) - USD ($) $ in Thousands	3 Months Ended
	Apr. 01, 2023	Apr. 02, 2022
Revenue, Major Customer [Line Items]
Total net sales	$ 684,674	$ 690,572
Pharmaceutical [Member]
Revenue, Major Customer [Line Items]
Total net sales	384,898	415,772
Industrial [Member]
Revenue, Major Customer [Line Items]
Total net sales	209,650	209,397
Academic and government [Member]
Revenue, Major Customer [Line Items]
Total net sales	$ 90,126	$ 65,403

Business Segment Information _5

Business Segment Information - Summary of Net Sales of Company Recognized at a Point in Time Versus Over Time (Detail) - USD ($) $ in Thousands	3 Months Ended
	Apr. 01, 2023	Apr. 02, 2022
Disaggregation of Revenue [Line Items]
Total net sales	$ 684,674	$ 690,572
Chemistry Consumables [Member]
Disaggregation of Revenue [Line Items]
Total net sales	133,515	125,618
Service [Member]
Disaggregation of Revenue [Line Items]
Total net sales	248,217	239,732
Net Sales Recognized at a Point in Time: [Member]
Disaggregation of Revenue [Line Items]
Total net sales	524,664	536,618
Net Sales Recognized at a Point in Time: [Member] | Instrument Systems [Member]
Disaggregation of Revenue [Line Items]
Total net sales	302,942	325,222
Net Sales Recognized at a Point in Time: [Member] | Chemistry Consumables [Member]
Disaggregation of Revenue [Line Items]
Total net sales	133,515	125,618
Net Sales Recognized at a Point in Time: [Member] | Service [Member]
Disaggregation of Revenue [Line Items]
Total net sales	88,207	85,778
Net Sales Recognized Over Time: [Member]
Disaggregation of Revenue [Line Items]
Total net sales	684,674	690,572
Net Sales Recognized Over Time: [Member] | Service [Member]
Disaggregation of Revenue [Line Items]
Total net sales	$ 160,010	$ 153,954